Viruxan® Forte – an expert in immunoprotection
Viruxan® Forte is a clinically proven OTC medicine and an easy-to-use solution for common cold and flu at adults with a unique dual mode of action. Viruxan® Forte with original IAD (Inosine Acedoben Dimepranol) molecule as active substance will be available as powder for oral solution in pharmacies in January 2022.
When a cold or a flu makes people feel sick
Cold and flu symptoms aren’t just annoyances that often keeps people on the couch all day. They actually indicate that their immune system is active and fighting off an infection. With Viruxan® Forte and its proven double effect, they can support their natural immune system to conquer the virus, not just its symptoms.
Power & protection against the cause of common cold and flu-like diseases
Viruxan® Forte’s active substance is original molecule of Inosine Acedoben Dimepranol (IAD) with a well-established safety profile and more than 50 years of real-life experience. It has been proven that Viruxan® Forte restores the proper function of immune system by increasing both the number and the function of several immune cells. It also shows non-specific antiviral activity, which means it is effective against a broad spectrum of viruses. As a result of this unique dual mode of action, Viruxan® Forte significantly reduces the duration and severity of acute respiratory viral infections.
References:
* Sliva J, Pantzartzi CN, Votava M. Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases. Adv Ther. 2019 Aug;36(8):1878-1905. doi: 10.1007/s12325-019-00995-6. Epub 2019 Jun 5. PMID: 31168764; PMCID: PMC6822865;
ABOUT VIRUXAN®
Viruxan® is a preferred OTC brand for the of the common cold and flu-like diseases. Viruxan® offers easy-to-use products with unique dual mode of action. Viruxan®’s expertise is based on trustworthy scientific foundation. Its effectiveness has been proven in clinical practice and it can provide a long history of real-life applications. www.viruxan.com
ABOUT EWOPHARMA
Ewopharma AG, headquartered in Schaffhausen, Switzerland, is a pharmaceutical marketing company focused on Central Eastern Europe and Switzerland. With nearly 60 years’ presence in the region, Ewopharma has extensive knowledge of these markets and enjoys a privileged position in the area. The company covers all aspects of market access and commercialisation of ethical pharmaceutical and consumer health products. www.ewopharma.com